Pharmaceutical Biotechnology Experts are professionals who apply advanced biological and biotechnological methods to develop new drugs and therapies. They focus on the use of living organisms, cells, and biological processes to create biologics such as monoclonal antibodies, therapeutic proteins, and vaccines. By harnessing the power of biotechnology, these experts are pioneering new treatments for complex diseases like cancer, diabetes, and genetic disorders. Their work plays a pivotal role in developing biologic therapies that offer personalized and targeted treatment options, improving the effectiveness and safety of healthcare. With the integration of cutting-edge technologies, these experts are at the forefront of developing next-generation treatments that can significantly alter disease progression.
These are work at the intersection of biology, chemistry, and pharmacology, using tools such as genetic engineering, cell culture, and gene editing techniques like CRISPR. Their primary goal is to optimize the production of high-quality biologic drugs while ensuring they are safe, scalable, and cost-effective for widespread use. Pharmaceutical biotechnology experts also navigate the complexities of regulatory approval processes, ensuring that new therapies meet the necessary standards for patient safety and efficacy. With the rise of biologic drugs in modern medicine, these professionals are critical in driving the innovation that addresses unmet medical needs and helps transform the future of healthcare.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India